Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
This study is currently recruiting participants.
Verified May 2013 by Lindner Center of HOPE
Study NCT01093963   Information provided by Lindner Center of HOPE

First Received on March 25, 2010.   Last Updated on May 8, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Depression
Additional conditions recognized in this trial
Bipolar Disorder
Depression
Depressive Disorder
More general conditions related to this trial
Affective Disorders, Psychotic
Behavioral Symptoms
Mental Disorders
Mood Disorders
Interventions listed in this trial
Lisdexamfetamine
Placebo
Additional drug interventions recognized in this trial
Dextroamphetamine
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Stimulants
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Lindner Center of HOPE
Shire Development LLC
University of Cincinnati


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services